A recent National Institutes of Health (NIH)-funded computational study analyzing genomic and drug data has been able to predict new uses for existing medicines. "If we can find ways to repurpose drugs that are already approved, we could improve treatments and save both time and money," says NIH's Rochelle M. Long.
The researchers, led by Stanford University's Atul J. Butte, focused on 100 diseases and 164 drugs, creating a computer program to search through the thousands of possible drug-disease combinations to find drugs and diseases whose gene expression patterns essentially canceled each other out.
The researchers noticed that diseases with similar molecular processes clustered together in the analysis, as did drugs with similar effects. By studying unexpected members of these clusters, it could be possible to learn how certain diseases progress and how some drugs work at the molecular level, according to the researchers.
From National Institutes of Health
View Full Article
Abstracts Copyright © 2011 Information Inc. , Bethesda, Maryland, USA